Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 9/2010

01.09.2010 | Original Paper

Epidemiology of antidepressant medication use in the Canadian diabetes population

verfasst von: Anna Ivanova, Danit Nitka, Norbert Schmitz

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Depression has been shown to be a common co-morbidity in diabetes. From a public health point of view, there is a lack of population-based studies regarding the use of antidepressant medication in non-clinical samples of people with diabetes. The objective of the present study was to provide demographic and clinical information about the use of antidepressant medication in a representative community sample of people with diabetes.

Method

The Canadian Community Health Survey 1.2 (CCHS 1.2) is a cross-sectional survey that collects information related to health status, health-care utilization and health determinants of the Canadian general population. Diabetes presence was ascertained by self-report of physician diagnosis. Depression and anxiety were assessed using a modified version of the World Mental Health Composite International Diagnostic Interview. Antidepressant use was determined through self-report.

Results

The population prevalence of self-reported antidepressant use in the past 12 months was 8.4% (SE = 0.95) among people with diabetes (n = 1,662). People who took antidepressants had higher average body mass index (M = 32.6, SD = 6.5) than those not taking antidepressants (M = 29.2, SD = 5.7). The use of antidepressants was associated with poorer health status and higher number of co-morbid chronic conditions. Half of diabetes subjects who used antidepressant medication in the last year did not have a lifetime history of major depression.

Conclusions

In a community sample of people with diabetes, the prevalence of antidepressant use exceeded the prevalence of major depression. Anxiety disorders and other somatic chronic conditions were associated with the prescription of antidepressant medication in people with diabetes, but without a history of major depression.
Literatur
1.
Zurück zum Zitat Andrews G, Slade T (2001) Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health 25:494CrossRefPubMed Andrews G, Slade T (2001) Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health 25:494CrossRefPubMed
2.
Zurück zum Zitat Beck CA, Patten SB, Williams JVA, Jian Li W, Currie SR, Maxwell CJ, El-Guebaly N (2005) Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 40:799–807CrossRefPubMed Beck CA, Patten SB, Williams JVA, Jian Li W, Currie SR, Maxwell CJ, El-Guebaly N (2005) Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 40:799–807CrossRefPubMed
3.
Zurück zum Zitat Cairney J, Veldhuizen S, Wade TJ, Kurdyak P, Streiner DL (2007) Evaluation of 2 measures of psychological distress as screeners for depression in the general population. Can J Psychiatry 52:111–120PubMed Cairney J, Veldhuizen S, Wade TJ, Kurdyak P, Streiner DL (2007) Evaluation of 2 measures of psychological distress as screeners for depression in the general population. Can J Psychiatry 52:111–120PubMed
4.
Zurück zum Zitat Demyttenaere K, Jaspers L (2008) Bupropion and SSRI-induced side effects. J Psychopharmacol 22:792–804CrossRefPubMed Demyttenaere K, Jaspers L (2008) Bupropion and SSRI-induced side effects. J Psychopharmacol 22:792–804CrossRefPubMed
5.
Zurück zum Zitat Deshmukh R, Franco K (2003) Managing weight gain as a side effect of antidepressant therapy. Cleve Clin J Med 70:614–623CrossRefPubMed Deshmukh R, Franco K (2003) Managing weight gain as a side effect of antidepressant therapy. Cleve Clin J Med 70:614–623CrossRefPubMed
6.
Zurück zum Zitat Furukawa TA, Kessler RC, Slade T, Andrews G (2003) The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychol Med 33:357–362CrossRefPubMed Furukawa TA, Kessler RC, Slade T, Andrews G (2003) The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychol Med 33:357–362CrossRefPubMed
7.
Zurück zum Zitat Ghaemi SN, Lenox MS, Baldessarini RJ (2001) Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 62:565–569PubMed Ghaemi SN, Lenox MS, Baldessarini RJ (2001) Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 62:565–569PubMed
8.
Zurück zum Zitat Gonzalez JS, Peyrot M, McCarl LA et al (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31:2398–2403CrossRefPubMed Gonzalez JS, Peyrot M, McCarl LA et al (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31:2398–2403CrossRefPubMed
9.
Zurück zum Zitat Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E et al (2007) Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 30:2222–2227CrossRefPubMed Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E et al (2007) Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 30:2222–2227CrossRefPubMed
10.
Zurück zum Zitat Goodnick PJ (2001) Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 13:31–41PubMed Goodnick PJ (2001) Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 13:31–41PubMed
11.
Zurück zum Zitat Hirschfeld R, Keller M, Panico S, Arons B, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman J, Marek R, Maurer T, Meyer R, Phillips K, Ross J, Schwenk T, Sharfstein S, Thase M, Wyatt R (1997) The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277:333–340CrossRefPubMed Hirschfeld R, Keller M, Panico S, Arons B, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman J, Marek R, Maurer T, Meyer R, Phillips K, Ross J, Schwenk T, Sharfstein S, Thase M, Wyatt R (1997) The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277:333–340CrossRefPubMed
12.
Zurück zum Zitat Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38:21–37CrossRefPubMed Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38:21–37CrossRefPubMed
13.
Zurück zum Zitat Katon W, Lin EHB, Kroenke K (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29:147–155CrossRefPubMed Katon W, Lin EHB, Kroenke K (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29:147–155CrossRefPubMed
14.
Zurück zum Zitat Katon WJ, Von Korff M, Lin EHB, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T (2004) The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042–1049CrossRefPubMed Katon WJ, Von Korff M, Lin EHB, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T (2004) The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042–1049CrossRefPubMed
15.
Zurück zum Zitat Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672CrossRefPubMed Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672CrossRefPubMed
16.
Zurück zum Zitat Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342:1462–1470CrossRefPubMed Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342:1462–1470CrossRefPubMed
17.
Zurück zum Zitat Kennedy SH (2006) A review of antidepressant treatments today. Eur Neuropsychopharmacol 16:S619–S623CrossRef Kennedy SH (2006) A review of antidepressant treatments today. Eur Neuropsychopharmacol 16:S619–S623CrossRef
18.
Zurück zum Zitat Kessler RC, Ustün TB (2004) The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) composite. International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13:93–121CrossRefPubMed Kessler RC, Ustün TB (2004) The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) composite. International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13:93–121CrossRefPubMed
19.
Zurück zum Zitat Kessler R, Andrews G, Colpe L, Hiripi E, Mroczek D, Normand S, Walters E, Zaslavsky A (2002) Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 32:959–976CrossRefPubMed Kessler R, Andrews G, Colpe L, Hiripi E, Mroczek D, Normand S, Walters E, Zaslavsky A (2002) Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 32:959–976CrossRefPubMed
20.
Zurück zum Zitat Lin EHB, Von Korff M (2008) Mental disorders among persons with diabetes-Results from the World Mental Health Surveys. J Pyschosom Res 65:571–580CrossRef Lin EHB, Von Korff M (2008) Mental disorders among persons with diabetes-Results from the World Mental Health Surveys. J Pyschosom Res 65:571–580CrossRef
21.
Zurück zum Zitat Lustman PJ, Freedland KE, Griffith LS, Clouse RE (2000) Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23:618–623CrossRefPubMed Lustman PJ, Freedland KE, Griffith LS, Clouse RE (2000) Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23:618–623CrossRefPubMed
22.
Zurück zum Zitat Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB (1997) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250PubMed Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB (1997) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250PubMed
23.
Zurück zum Zitat Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE (1998) Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 129:613–621PubMed Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE (1998) Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 129:613–621PubMed
24.
Zurück zum Zitat McCollum M, Ellis SL, Regensteiner JG, Zhang W, Sullivan PW (2007) Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care 13:65–72PubMed McCollum M, Ellis SL, Regensteiner JG, Zhang W, Sullivan PW (2007) Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care 13:65–72PubMed
25.
Zurück zum Zitat McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 5:157–168CrossRefPubMed McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 5:157–168CrossRefPubMed
26.
Zurück zum Zitat McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf 5:523–537CrossRefPubMed McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf 5:523–537CrossRefPubMed
27.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289:76–79CrossRefPubMed Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289:76–79CrossRefPubMed
28.
Zurück zum Zitat National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6:51–209 National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6:51–209
29.
Zurück zum Zitat Ohayon MM, Caulet M, Priest RG, Guilleminault C (1998) Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 51:273–283CrossRefPubMed Ohayon MM, Caulet M, Priest RG, Guilleminault C (1998) Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 51:273–283CrossRefPubMed
30.
Zurück zum Zitat Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57:1096–1103CrossRefPubMed Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57:1096–1103CrossRefPubMed
31.
Zurück zum Zitat Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
32.
Zurück zum Zitat Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE et al (2008) Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31:420–426CrossRefPubMed Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE et al (2008) Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31:420–426CrossRefPubMed
33.
Zurück zum Zitat Statistics Canada (2002) A profile of disability in Canada. Canadian Research Index 2002, Ottawa Statistics Canada (2002) A profile of disability in Canada. Canadian Research Index 2002, Ottawa
34.
Zurück zum Zitat The Diabetes Prevention Program Research Group (2005) Depression symptoms and antidepressant medicine use in diabetes prevention program participants. Diabetes Care 28:830–837CrossRef The Diabetes Prevention Program Research Group (2005) Depression symptoms and antidepressant medicine use in diabetes prevention program participants. Diabetes Care 28:830–837CrossRef
35.
Zurück zum Zitat Tunks ER, Weir R, Crook J (2008) Epidemiologic perspective on chronic pain treatment. Can J Psychiatry 53:235–242PubMed Tunks ER, Weir R, Crook J (2008) Epidemiologic perspective on chronic pain treatment. Can J Psychiatry 53:235–242PubMed
36.
Zurück zum Zitat Williams JW Jr, Katon W, Lin EHB, Noel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unutzer J (2004) The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140:1015–1024PubMed Williams JW Jr, Katon W, Lin EHB, Noel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unutzer J (2004) The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140:1015–1024PubMed
37.
Zurück zum Zitat Wittchen HU (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28:57–84CrossRefPubMed Wittchen HU (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28:57–84CrossRefPubMed
Metadaten
Titel
Epidemiology of antidepressant medication use in the Canadian diabetes population
verfasst von
Anna Ivanova
Danit Nitka
Norbert Schmitz
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 9/2010
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-009-0129-y

Weitere Artikel der Ausgabe 9/2010

Social Psychiatry and Psychiatric Epidemiology 9/2010 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.